References
- Ashburner M, Ball CA, Blake JA, et al (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 25, 25-9. https://doi.org/10.1038/75556
- Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
- Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33. https://doi.org/10.1016/j.cell.2009.01.002
- Benjamini YH, Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Royal Statist Society Series B (Methodological), 57, 289-300.
- Butt AJ, Caldon CE, McNeil CM, et al. (2008). Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol, 630, 189-205. https://doi.org/10.1007/978-0-387-78818-0_12
- Carroll MC (2004). The complement system in regulation of adaptive immunity. Nat Immunol, 5, 981-6. https://doi.org/10.1038/ni1113
- Colomiere M, Ward AC, Riley C, et al (2009). Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer, 100, 134-44. https://doi.org/10.1038/sj.bjc.6604794
- D'Andrilli G, Kumar C, Scambia G, Giordano A (2004). Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies. Clin Cancer Res, 10, 8132-41. https://doi.org/10.1158/1078-0432.CCR-04-0886
- Elledge SJ (1996). Cell cycle checkpoints: preventing an identity crisis. Science, 274, 1664-72. https://doi.org/10.1126/science.274.5293.1664
- Gautier L, Cope L, Bolstad BM, Irizarry RA (2004). affy-- analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-15. https://doi.org/10.1093/bioinformatics/btg405
- Holschneider CH, Berek JS (2000). Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol, 19, 3-10. https://doi.org/10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S
- Hsu SD, Lin FM, Wu WY, et al (2011). miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res, 39, D163-9. https://doi.org/10.1093/nar/gkq1107
- Huang Q, Gumireddy K, Schrier M, et al (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol, 10, 202-10. https://doi.org/10.1038/ncb1681
- Iorio MV, Visone R, Di Leva G, et al (2007). MicroRNA signatures in human ovarian cancer. Cancer Res, 67, 8699- 707. https://doi.org/10.1158/0008-5472.CAN-07-1936
- Irizarry RA, Hobbs B, Collin F, et al (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-64. https://doi.org/10.1093/biostatistics/4.2.249
- Johnson SM, Grosshans H, Shingara J, et al (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635-47. https://doi.org/10.1016/j.cell.2005.01.014
- Kusenda B, Mraz M, Mayer J, Pospisilova S (2006). MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 150, 205-15. https://doi.org/10.5507/bp.2006.029
- Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54. https://doi.org/10.1016/0092-8674(93)90529-Y
- Lee YS, Dutta A (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev, 21, 1025-30. https://doi.org/10.1101/gad.1540407
- Ma L, Teruya-Feldstein J, Weinberg RA (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682-8. https://doi.org/10.1038/nature06174
- Meng F, Henson R, Wehbe-Janek H, et al (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-58. https://doi.org/10.1053/j.gastro.2007.05.022
- Min H, Yoon S (2010). Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med, 42, 233-44. https://doi.org/10.3858/emm.2010.42.4.032
- Mok SC, Bonome T, Vathipadiekal V, et al (2009). A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell, 16, 521-32. https://doi.org/10.1016/j.ccr.2009.10.018
- Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM (2005). Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett, 97, 171-9. https://doi.org/10.1016/j.imlet.2004.11.010
- Murray KP, Mathure S, Kaul R, et al (2000). Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. Gynecol Oncol, 76, 176-82. https://doi.org/10.1006/gyno.1999.5614
- Nam EJ, Kim YT (2008). Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol Cancer, 18, 1169-82. https://doi.org/10.1111/j.1525-1438.2008.01191.x
- Nam EJ, Yoon H, Kim SW, et al. (2008). MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res, 14, 2690-95. https://doi.org/10.1158/1078-0432.CCR-07-1731
- Ono K, Tanaka T, Tsunoda T, et al (2000). Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res, 60, 5007-11.
- Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA (2007). Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet, 3, e42. https://doi.org/10.1371/journal.pgen.0030042
- Ricklin D, Lambris JD (2007). Complement-targeted therapeutics. Nat Biotechnol, 25, 1265-75. https://doi.org/10.1038/nbt1342
- Team RDC (2011). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing.
- van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA (2010). MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol, 42, 1282-90. https://doi.org/10.1016/j.biocel.2010.01.014
- Voorhoeve PM, le Sage C, Schrier M, et al (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 124, 1169-81. https://doi.org/10.1016/j.cell.2006.02.037
- Wang J, Zhou X, Zhu J, et al (2011). GO-function: deriving biologically relevant functions from statistically significant functions. Brief Bioinform.
- Wightman B, Ha I, Ruvkun G (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 75, 855-62. https://doi.org/10.1016/0092-8674(93)90530-4
- Zhang L, Huang J, Yang N, et al (2006). microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA, 103, 9136-41. https://doi.org/10.1073/pnas.0508889103
Cited by
- miR-186 Regulates Glycolysis through Glut1 During the Formation of Cancer-associated Fibroblasts vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4245
- Lack of Any Association of GST Genetic Polymorphisms with Susceptibility to Ovarian Cancer - a Meta-analysis vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6131
- MicroRNAs: Biogenesis, Roles for Carcinogenesis and as Potential Biomarkers for Cancer Diagnosis and Prognosis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7489
- Differential microRNA Expression by Solexa Sequencing in the Sera of Ovarian Cancer Patients vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1739
- MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer vol.233, pp.3, 2014, https://doi.org/10.1002/path.4348
- Can Cancer Therapy be Achieved by Bridging Apoptosis and Autophagy: a Method Based on microRNA-Dependent Gene Therapy and Phytochemical Targets vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7435